Author:
Rakočević Jelena,Tomašević Miloje,Aleksandrić Srđan,Stojković Siniša,Nedeljković Milan
Publisher
Centre for Evaluation in Education and Science (CEON/CEES)
Reference50 articles.
1. Fuster V, Badimon L, Badimon JJ, et al. Mechanisms of disease -the pathogenesis of coronary-artery disease and the acute coronary syndromes. N Engl J Med1992;326:310-8.;
2. Bhatt DL, Hulot J-S, Moliterno DJ, et al. Antiplatelet and Antico- agulation Therapy for Acute Coronary Syndromes. Circ Res 2014;114(12):1929-43.;
3. Udell JA, Bonaca MP, Collet JP, et al. Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a col- laborative meta-analysis of randomized trials. Eur Heart J 2016; 37:390-9.;
4. Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease devel- oped in collaboration with EACTS: The Task Force for dual anti- platelet therapy in coronary artery disease of the European So- ciety of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2017; doi: 10.1093/ eurheartj/ehx419.;
5. Vane JR, Botting RM. The mechanism of action of aspirin. Thromb Res 2003;110(5-6):255-8.;